132 related articles for article (PubMed ID: 23819613)
1. Atherogenic dyslipidaemic profiles associated with the development of Type 2 diabetes: a 3.1-year longitudinal study.
Hwang YC; Ahn HY; Yu SH; Park SW; Park CY
Diabet Med; 2014 Jan; 31(1):24-30. PubMed ID: 23819613
[TBL] [Abstract][Full Text] [Related]
2. Apolipoprotein B and non-HDL cholesterol are more powerful predictors for incident type 2 diabetes than fasting glucose or glycated hemoglobin in subjects with normal glucose tolerance: a 3.3-year retrospective longitudinal study.
Hwang YC; Ahn HY; Park SW; Park CY
Acta Diabetol; 2014 Dec; 51(6):941-6. PubMed ID: 24816996
[TBL] [Abstract][Full Text] [Related]
3. Associations of multiple lipoprotein and apolipoprotein measures with worsening of glycemia and incident type 2 diabetes in 6607 non-diabetic Finnish men.
Fizelova M; Miilunpohja M; Kangas AJ; Soininen P; Kuusisto J; Ala-Korpela M; Laakso M; Stančáková A
Atherosclerosis; 2015 May; 240(1):272-7. PubMed ID: 25818853
[TBL] [Abstract][Full Text] [Related]
4. Plasma Apolipoproteins Predicting the Occurrence and Severity of Diabetic Retinopathy in Patients With Type 2 Diabetes Mellitus.
Zhang X; Nie Y; Gong Z; Zhu M; Qiu B; Wang Q
Front Endocrinol (Lausanne); 2022; 13():915575. PubMed ID: 35937834
[TBL] [Abstract][Full Text] [Related]
5. High level of individual lipid profile and lipid ratio as a predictive marker of poor glycemic control in type-2 diabetes mellitus.
Artha IMJR; Bhargah A; Dharmawan NK; Pande UW; Triyana KA; Mahariski PA; Yuwono J; Bhargah V; Prabawa IPY; Manuaba IBAP; Rina IK
Vasc Health Risk Manag; 2019; 15():149-157. PubMed ID: 31239693
[No Abstract] [Full Text] [Related]
6. Factors Associated with Poor Glycemic and Lipid Levels in Ambulatory Diabetes Mellitus Type 2 Patients in Asmara, Eritrea: A Cross-Sectional Study.
Achila OO; Ghebretinsae M; Kidane A; Simon M; Makonen S; Rezene Y
J Diabetes Res; 2020; 2020():5901569. PubMed ID: 32090121
[TBL] [Abstract][Full Text] [Related]
7. Increased apoB/A-I ratio independently associated with Type 2 diabetes mellitus: cross-sectional study in a Korean population.
Hwang YC; Ahn HY; Kim WJ; Park CY; Park SW
Diabet Med; 2012 Sep; 29(9):1165-70. PubMed ID: 22356423
[TBL] [Abstract][Full Text] [Related]
8. Non-HDL cholesterol and apolipoprotein B predict cardiovascular disease events among men with type 2 diabetes.
Jiang R; Schulze MB; Li T; Rifai N; Stampfer MJ; Rimm EB; Hu FB
Diabetes Care; 2004 Aug; 27(8):1991-7. PubMed ID: 15277429
[TBL] [Abstract][Full Text] [Related]
9. An equation to estimate the concentration of serum apolipoprotein B.
Hwang YC; Ahn HY; Lee WJ; Park CY; Park SW
PLoS One; 2012; 7(12):e51607. PubMed ID: 23284722
[TBL] [Abstract][Full Text] [Related]
10. Components of metabolic syndrome and 5-year change in insulin clearance - the Insulin Resistance Atherosclerosis Study.
Lee CC; Lorenzo C; Haffner SM; Wagenknecht LE; Goodarzi MO; Stefanovski D; Norris JM; Rewers MJ; Hanley AJ
Diabetes Obes Metab; 2013 May; 15(5):441-7. PubMed ID: 23216702
[TBL] [Abstract][Full Text] [Related]
11. Non-high-density lipoprotein cholesterol is associated more closely with albuminuria in Chinese type 2 diabetic patients with normal renal function, compared with traditional lipid parameters.
Pan J; Gao F; Bao Y; Zhang L; Tu Y; Jia W
J Clin Lipidol; 2012; 6(4):382-7. PubMed ID: 22836076
[TBL] [Abstract][Full Text] [Related]
12. Plasma proprotein convertase subtilisin kexin type 9 is not altered in subjects with impaired glucose metabolism and type 2 diabetes mellitus, but its relationship with non-HDL cholesterol and apolipoprotein B may be modified by type 2 diabetes mellitus: The CODAM study.
Brouwers MC; Troutt JS; van Greevenbroek MM; Ferreira I; Feskens EJ; van der Kallen CJ; Schaper NC; Schalkwijk CG; Konrad RJ; Stehouwer CD
Atherosclerosis; 2011 Jul; 217(1):263-7. PubMed ID: 21497351
[TBL] [Abstract][Full Text] [Related]
13. Considerably decreased risk of cardiovascular disease with combined reductions in HbA1c, blood pressure and blood lipids in type 2 diabetes: Report from the Swedish National Diabetes Register.
Eeg-Olofsson K; Zethelius B; Gudbjörnsdottir S; Eliasson B; Svensson AM; Cederholm J
Diab Vasc Dis Res; 2016 Jul; 13(4):268-77. PubMed ID: 27190080
[TBL] [Abstract][Full Text] [Related]
14. Non-HDL-cholesterol in an adolescent diabetes population.
Kuryan RE; Jacobson MS; Frank GR
J Clin Lipidol; 2014; 8(2):194-8. PubMed ID: 24636179
[TBL] [Abstract][Full Text] [Related]
15. Additive effects of glycaemia and dyslipidaemia on risk of cardiovascular diseases in type 2 diabetes: an observational study from the Swedish National Diabetes Register.
Gudbjörnsdottir S; Eliasson B; Eeg-Olofsson K; Zethelius B; Cederholm J;
Diabetologia; 2011 Oct; 54(10):2544-51. PubMed ID: 21674176
[TBL] [Abstract][Full Text] [Related]
16. Lipid and liver abnormalities in haemoglobin A1c-defined prediabetes and type 2 diabetes.
Calanna S; Scicali R; Di Pino A; Knop FK; Piro S; Rabuazzo AM; Purrello F
Nutr Metab Cardiovasc Dis; 2014 Jun; 24(6):670-6. PubMed ID: 24656139
[TBL] [Abstract][Full Text] [Related]
17. Association of HDL-C and apolipoprotein A-I with the risk of type 2 diabetes in subjects with impaired fasting glucose.
Hwang YC; Ahn HY; Park SW; Park CY
Eur J Endocrinol; 2014 Jul; 171(1):137-42. PubMed ID: 24760540
[TBL] [Abstract][Full Text] [Related]
18. Relationship between HbA1c and Lipid Profile Seen in Bangladeshi Type 2 Diabetes Mellitus Patients Attending BIRDEM Hospital: A Cross-Sectional Study.
Begum A; Irfan SR; Hoque MR; Habib SH; Parvin S; Malek R; Akhter S; Sattar S; Sarkar S
Mymensingh Med J; 2019 Jan; 28(1):91-95. PubMed ID: 30755556
[TBL] [Abstract][Full Text] [Related]
19. Effect of age on the association of non-high-density-lipoprotein cholesterol and apolipoprotein B with cardiovascular mortality in a Mediterranean population with type 2 diabetes: the Casale Monferrato study.
Bruno G; Merletti F; Biggeri A; Bargero G; Prina-Cerai S; Pagano G; Cavallo-Perin P
Diabetologia; 2006 May; 49(5):937-44. PubMed ID: 16525840
[TBL] [Abstract][Full Text] [Related]
20. Ciprofibrate effects on carbohydrate and lipid metabolism in type 2 diabetes mellitus subjects.
Hernández-Mijares A; Lluch I; Vizcarra E; Martínez-Triguero ML; Ascaso JF; Carmena R
Nutr Metab Cardiovasc Dis; 2000 Feb; 10(1):1-6. PubMed ID: 10812581
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
